Timing of Revascularization in Patients with Acute Coronary Syndrome: Why Is Earlier Better?

Multivessel coronary artery disease is present in up to half of patients presenting with acute coronary syndrome (1). While the debate regarding the treatment of multivessel disease in the setting of ST-elevation myocardial infarction (STEMI) has largely been settled, compelling evidence to guide the timing of complete revascularization in the setting of non-ST-elevation myocardial infarction (NSTEMI) has been lacking. Two recent trials directly address this topic (2,3) and prompted Cheema and colleagues to complete a systemic review and meta-analysis (4).
Source: The American Journal of Cardiology - Category: Cardiology Authors: Tags: Editorial Source Type: research